N-acetylcysteine in heavy smokers: A double-blind randomized controlled trial.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON21561

Enrollment

Registered

2010-02-08

Start date

2010-02-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nicotine dependence

Interventions

1. 4 day administration of 3600 mg of N-acetylcysteine

2. 4 day administration of placebo.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Undergraduate students; 2. Smoking minimum of 15 sigarettes a day.

Exclusion criteria

Exclusion criteria: 1. Major illnesses; 2. Dependent on any other substance other than nicotine; 3. Currently on medication other than birth control; 4. Pregnant or planning to become pregnant; 5. Ulcers; 6. Color blind.

Design outcomes

Primary

Measure	Time frame
1. Self-reported craving; 2. Self-reported withdrawal symptoms; 3. Neurocognitive tasks.	—

Contacts

Public ContactL. Schmaal

Postbus 22660

l.schmaal@amc.uva.nl+31 (0)20 8913762

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)